About the Presenter
Dr. Saul Priceman is a trained tumor immunologist with expertise in T cell biology and cancer immunotherapy. He received his PhD in 2010 from UCLA, and did his post-doctoral training at City of Hope (COH), where he is now an Assistant Professor. The Priceman Lab focuses on translational research relevant to developing innovative cellular immunotherapy for the treatment of solid tumors, including prostate cancer. His research interests are centered on cellular immunotherapy, primarily using Car-T cell therapy.
Dr. Priceman will speak on these modalities and on new mechanisms of action, including the new BiTE mechanism of immuno-oncology. Dr. Priceman has authored or co-authored over 30 publications in the field of cancer immunotherapy, and was interviewed for the November Issue of PROSTATEPEDIA Magazine published by NASPCC, which centered on the topic of Immuno-Oncology and PARP Inhibition.